| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 04/13/2004 | US6720338 Bcl-x1 inhibiting compositions and methods of promoting apoptosis in a mammal |
| 04/13/2004 | US6720335 Sulfonamide inhibitors of aspartyl protease |
| 04/08/2004 | WO2004028539A2 1h-imidazo dimers |
| 04/08/2004 | WO2004014361A9 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity |
| 04/08/2004 | WO2004013103A3 Process for preparing quinolone antibiotic intermediates |
| 04/08/2004 | WO2004010761A3 Pesticidal cyanine dye derivatives |
| 04/08/2004 | WO2003057225A3 Phosphate transport inhibitors |
| 04/08/2004 | US20040068012 Anticancer agents; protease enzyme inhibitor |
| 04/08/2004 | US20040068001 Using hydroxy-3-methylglutaryl/3-/ coenzyme inhibitor |
| 04/08/2004 | US20040067981 Acetylcholinesterase inhibitor; Alzheimer's diseases, Hubtington disease, antidepressants |
| 04/08/2004 | US20040067980 Inhibitors of the GPIb-vWF interaction, their preparation and use |
| 04/08/2004 | US20040067944 Antiarrhythmia agents |
| 04/08/2004 | US20040067940 Antiischemic agents; antiinflammatory agents; antiallergens; autoimmune disease |
| 04/07/2004 | EP1405848A1 Tetrahydroquinoline derivative compound and drug containing the compound as active ingredient |
| 04/07/2004 | EP1404659A1 4-aryl quinols and analogs thereof as therapeutic agents |
| 04/07/2004 | EP1404330A1 Substituted 8-arylquinoline pde4 inhibitors |
| 04/07/2004 | EP1404329A1 Substituted 4-aryl-3-(3-aryl-1-oxo-2-propenyl)-2(1h)-quinolinones and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 04/07/2004 | EP0973512B1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 04/07/2004 | CN1486980A Prepn process of 2.4-dichloro-6.7-dimethoxy quinazoline |
| 04/07/2004 | CN1144793C Polar-substituted hydrocarbons |
| 04/07/2004 | CN1144786C Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 04/06/2004 | US6716852 Amino acid derivatives and use thereof as NEP, ACE and ECE inhibitors |
| 04/06/2004 | CA2223927C Detection of transmembrane potentials by optical methods |
| 04/01/2004 | WO2004026838A1 Method for producing a 3,5-dihydroxy-6-heptenoate |
| 04/01/2004 | WO2004026837A2 Histamine h3 receptor antagonists, preparaton and therapeutic uses |
| 04/01/2004 | WO2004026836A2 1-pyridin-4-yl-urea derivatives |
| 04/01/2004 | WO2004026823A1 Amide and sulfonamide ligands for the estrogen receptor |
| 04/01/2004 | WO2004026815A2 Phenol derivatives and their use as rotamase inhibitors |
| 04/01/2004 | WO2004026292A1 Antitussives |
| 04/01/2004 | WO2003106425A3 Phenyl- and pyridyl-diazaheterocycles having a tnf-modulating activity |
| 04/01/2004 | WO2003099284B1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 04/01/2004 | WO2003093239A3 Process for the preparation of quinoline derivatives |
| 04/01/2004 | WO2003066597A3 Guanidino compounds |
| 04/01/2004 | US20040063959 Esters and amides as PLA2 inhibitors |
| 04/01/2004 | US20040063955 Antichoelsterol agents; cardiovascular disorders; antihistamines; multiple sclerosis; antihistamines |
| 04/01/2004 | US20040063952 Process for preparing quinolone antibiotic intermediates |
| 04/01/2004 | US20040063783 Used to treat pathologies characterized by an oxidative stress condition and a lack of availability of endothelial nitrogen monoxide, such as ischemia, restenosis, erectile dysfunction, hypoxia, transplant rejection and diabetes |
| 04/01/2004 | US20040063760 Sodium channel modulatiors |
| 04/01/2004 | US20040063757 Urotensin-ll receptor antagonists |
| 04/01/2004 | US20040063756 Administering a therapeutically effective amount of 2-Aminoquinolines for the prevention or treatment of eating disorders, weight gain and obesity |
| 04/01/2004 | US20040063755 Aromatic compounds containing hydroxyalkylaminoalkylphenylaminophenyl group; useful for treating pre-term labor, neurological disorders and cardiac disorders |
| 04/01/2004 | US20040063753 N-acetoamino-4-one-Pyridine derivatives are used as Lp-PLA2 (lipoprotein Associated Phospholipase A2) enzyme inhibitor |
| 04/01/2004 | US20040063698 Inflammatory disorders; such as N-hydroxy-2-(2-(4-(2-methyl-quinolin-4-ylmethoxy)-phenyl)-tetrahydro-furan-2-yl)-acet-amide |
| 04/01/2004 | US20040062713 Dye; photosensitive stimulant; using eye |
| 04/01/2004 | CA2499490A1 Amide and sulfonamide ligands for the estrogen receptor |
| 04/01/2004 | CA2498662A1 Phenol derivatives and their use as rotamase inhibitors |
| 04/01/2004 | CA2496624A1 1-pyridin-4-yl-urea derivatives |
| 03/31/2004 | EP1403247A1 N-Alkanoylphenylalanine derivatives |
| 03/31/2004 | EP1402890A1 Sulfonamide derivatives |
| 03/31/2004 | EP1402888A1 The use of substituted carbocyclic compounds as rotamases inhibitors |
| 03/31/2004 | EP1401833A2 Chemical derivatives and the use thereof as an anti-elomerase agent |
| 03/31/2004 | EP1401806A1 Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents |
| 03/31/2004 | EP1401801A1 Selective androgen receptor modulators and methods of use thereof |
| 03/31/2004 | EP1401503A1 Pharmaceutical compositions containing a solid dispersion of a poorly-soluble drug in a matrix and a solubility-enhancing polymer |
| 03/31/2004 | EP1401446A1 Tetrahydroquinolin derivatives for the inhibition of diseases associated with estrogen deprivation or with an aberrant physiological response to endogenous estrogen |
| 03/31/2004 | EP1401443A1 Novel anti-infectives |
| 03/31/2004 | EP1037865A4 Synthesis of cc-1065/duocarmycin analogs |
| 03/31/2004 | EP0871439B1 Substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) hydroxamic acid compounds |
| 03/31/2004 | CN1486308A Piperazinylcarbonylquinolines and -isoquinolines |
| 03/31/2004 | CN1486302A Abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 03/31/2004 | CN1143857C Bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitors |
| 03/30/2004 | US6713650 ABCA-1 elevating compounds |
| 03/30/2004 | US6713489 Treatment of atherosclerosis, obesity, diabetes, hyperlipidemia, hyperlipoproteinemia, hypercholesterolemia, hypertriglyceridemia, hypoalphalipoproteinemia, pancreatitis, myocardial infarction, stroke, restenosis, or syndrome x |
| 03/30/2004 | CA2079706C Inhibitor of atherosclerotic intimal thickening |
| 03/25/2004 | WO2004024693A1 Heterocyclic compound having hiv integrase inhibitory activity |
| 03/25/2004 | WO2004024081A2 Acetyl 2-hydroxy-1,3 diaminoalkanes |
| 03/25/2004 | WO2003069350A3 Small molecule modulators of apoptosis |
| 03/25/2004 | WO2003041728A8 Novel phenyl-propargylether derivatives |
| 03/25/2004 | WO2002088085A3 Methods and intermediates for preparing 4-aminoquinoline cetp inhibitors |
| 03/25/2004 | US20040059116 Aryl aniline beta2 adrenergic receptor agonists |
| 03/25/2004 | US20040058964 Antiinflammatory agents; antiarthritic agents; antihistamines; sepsis shock; antidiabetic agents; bone disorders |
| 03/25/2004 | US20040058962 Central nervus system diosrders; muscular disorders; incontinence |
| 03/25/2004 | US20040058937 Heterocyclic mutilin esters and their use as antibacterials |
| 03/25/2004 | US20040058935 Crystals; storage stability; psychological disorders |
| 03/25/2004 | US20040058931 Potassium channel inhibitors and method |
| 03/25/2004 | US20040058913 Cyclic diamine compound with condensed-ring groups |
| 03/25/2004 | US20040058820 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis |
| 03/25/2004 | DE10163295B4 Seltenerdmetall-Verbindungen und Gemische von diesen, Verfahren zu deren Herstellung sowie deren Verwendung Rare earth metal compounds and mixtures of these, processes for their preparation and their use |
| 03/25/2004 | CA2498248A1 Acetyl 2-hydroxy-1,3 diaminoalkanes |
| 03/24/2004 | EP1400510A1 Cyclic diamine compounds having fused-ring groups |
| 03/24/2004 | EP1399444A2 Novel heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents |
| 03/24/2004 | EP1399431A2 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 03/24/2004 | EP1399423A2 Anthranilic acid amides with a heteroarylsulfonyl side chain, method for the production thereof, use thereof as a medicament or diagnostic agent and pharmaceutical preparations containing said compounds |
| 03/24/2004 | EP1399190A1 Pharmaceutical compositions comprising low-solubility and/or acid-sensitive drugs and neutralized acidic polymers |
| 03/24/2004 | EP1399146A1 Novel compounds and compositions as cathepsin inhibitors |
| 03/24/2004 | CN1484524A 5-HT IA veceptor subtype agonist |
| 03/24/2004 | CN1483724A High-purity 8-hydroxyquinoline aluminium group compound, preparation method and use thereof |
| 03/24/2004 | CN1142912C Amide derivs, useful as inhibitors for production of cytokines |
| 03/24/2004 | CN1142793C Epoxy-steroidal aldosterone antagonist and angiotensin 2 antagonist combination therapy for treatment of congestive heart failure |
| 03/23/2004 | US6711394 RF receiver having cascaded filters and an intermediate amplifier stage |
| 03/23/2004 | US6710209 Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 03/23/2004 | US6710205 Benzoic acid derivatives, processes for producing the same and drugs containing the same as the active ingredient |
| 03/23/2004 | US6710056 Pharmaceutically acceptable salts thereof have an excellent antagonistic effect against activated blood coagulation factor vii. |
| 03/18/2004 | WO2004022542A2 Substituted 1,2,3,4-tetrahydroquinoline derivatives |
| 03/18/2004 | WO2004022541A1 1,4-substituted cyclohexane derivatives |
| 03/18/2004 | WO2004022528A2 Arylglycine derivatives and their use as glycine transport inhibitors |
| 03/18/2004 | WO2004022526A1 Cathepsin cysteine protease inhibitors |
| 03/18/2004 | WO2004022523A2 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 03/18/2004 | WO2004007459A3 Naphthol, quinoline and isoquinoline-derivatives as modulators of vanilloid vr1 receptor |
| 03/18/2004 | WO2003094919A3 Novel crystalline forms of gatifloxacin |